qader , ghulam md , dph, mph senior technical advisor, tb care i/msh, afghanistan

10
1 Identifying Contribution of Community-based DOTS in Treatment Outcome of TB Patients in Four Provinces of Afghanistan Qader, Ghulam MD, DPH, MPH Senior Technical Advisor, TB CARE I/MSH, Afghanistan

Upload: ayasha

Post on 25-Feb-2016

30 views

Category:

Documents


0 download

DESCRIPTION

Identifying Contribution of Community-based DOTS in Treatment Outcome of TB Patients in Four Provinces of Afghanistan. Qader , Ghulam MD , DPH, MPH Senior Technical Advisor, TB CARE I/MSH, Afghanistan. Objectives. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Qader , Ghulam MD , DPH,  MPH Senior Technical Advisor, TB CARE I/MSH, Afghanistan

1

Identifying Contribution of Community-based DOTS in Treatment Outcome of TB Patients in

Four Provinces of AfghanistanQader, Ghulam MD, DPH, MPH

Senior Technical Advisor, TB CARE I/MSH, Afghanistan

Page 2: Qader , Ghulam MD , DPH,  MPH Senior Technical Advisor, TB CARE I/MSH, Afghanistan

2

Objectives• To present the community-based

DOTS (CB-DOST) approach that applied in Afghanistan from 2009 to 2012

• To review results from community health workers’ (CHWs) contribution to TB patients' treatment adherence through community-based DOTS

Page 3: Qader , Ghulam MD , DPH,  MPH Senior Technical Advisor, TB CARE I/MSH, Afghanistan

3

Background• The USAID-funded TB CARE I project launched CB-

DOTS in 2009

• Trained 3,000 CHWs from Badakhshan, Baghlan, Jowzjan, and Hirat in: TB suspect identification and referral, Health education for the community and TB

patients, Direct Observed Treatment (DOT) provision, and Follow up examinations

• Role of CHWs in treatment outcome was not measured

Page 4: Qader , Ghulam MD , DPH,  MPH Senior Technical Advisor, TB CARE I/MSH, Afghanistan

4

TB CARE 1 Presence in Afghanistan

4

Page 5: Qader , Ghulam MD , DPH,  MPH Senior Technical Advisor, TB CARE I/MSH, Afghanistan

5

Method• Study design: Prospective cohort

• Data collection tool: collected gender and treatment outcomes

• Study site: Four provinces in Afghanistan

• Study subject: Intervention group: new sputum smear positive

(SS+) TB patients who were diagnosed and received DOT from CHWs

Control group: new SS+ TB patients who received DOT at health facilities or treatment supporters

Page 6: Qader , Ghulam MD , DPH,  MPH Senior Technical Advisor, TB CARE I/MSH, Afghanistan

6

Method (cont.)• Sample size: 4,058

Intervention group: 853

Control group: 3,205

• Confidence interval: 95%

• Statistical power: 95%

• Relative risk: 1.1

• Odds ratio: 1.7

• Proportion of exposed to unexposed: 3.6

Page 7: Qader , Ghulam MD , DPH,  MPH Senior Technical Advisor, TB CARE I/MSH, Afghanistan

7

Results• Enrollment: • Intervention group: 853

Female: 587 Male: 266

• Control group: 3,205

• Treatment outcome in intervention group: 97.65% p<0,00001

Page 8: Qader , Ghulam MD , DPH,  MPH Senior Technical Advisor, TB CARE I/MSH, Afghanistan

8

Results (cont.)Indicator CHW

Outcomes in 4 Provinces

N = 853(2010)

CHW and Health Facility Outcomes in 4 Provinces N =

3,205(2010)

National OutcomesN = 12,797

(2010)

Treatment success rate

833 (98%) 2,909 (90.7%) 11,624 (91%)

Cure rate 822 (96.4%) 2,855 (89%) 11,175 (87%)Completion rate 11 (1.2%) 54 (1.7%) 449 (4%)Death rate 10 (1.1%) 57 (1.8%) 257 (2%)Default rate 3 (0.4%) 54 (1.7%) 244 (2%)Failure to treat rate

3 (0.4%) 25 (0.8%) 122 (1%)

Transfer-out rate

4 (0.4%) 160 (5%) 550 (4%)

Page 9: Qader , Ghulam MD , DPH,  MPH Senior Technical Advisor, TB CARE I/MSH, Afghanistan

9

Conclusion/Recommendation• DOT provision by CHWs resulted in a

significant improvement in treatment success rate of new TB SS+ patient.

• Deaths, default, and failure rates declined significantly.

• It is recommend that National TB Program (NTP) scale-up CB-DOTS into similar settings

Page 10: Qader , Ghulam MD , DPH,  MPH Senior Technical Advisor, TB CARE I/MSH, Afghanistan

10

Thank you Qader, Ghulam, MD, DPH, MPH

Email: [email protected]: +93 797 261 407